AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35988569 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation (physiotherapy)
Number of subjects: 316
Study 35988569 — intervention group
Group type: COMPARATOR
Intervention: Comparison of surgical reconstruction to rehabilitation
Number of subjects: 316
Study 32530733 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose EV71 vaccination
Number of subjects: 408664
Study 32997262 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium Laser Enucleation of the Prostate (ThuLEP)
Number of subjects: 236
Study 32997262 — intervention group
Group type: COMPARATOR
Intervention: Holmium Laser Enucleation of the Prostate (HoLEP)
Number of subjects: 236
Study 32539432 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training in family-centered relational skills strategy (LAFF)
Number of subjects: 15
Study 32129511 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administration of romiplostim (n = 621)
Number of subjects: 754
Study 32129511 — intervention group
Group type: COMPARATOR
Intervention: HCP administration of romiplostim (n = 133)
Number of subjects: 754
Study 32129511 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administration of romiplostim
Number of subjects: 754
Study 32129511 — intervention group
Group type: COMPARATOR
Intervention: HCP administration of romiplostim
Number of subjects: 754
Study 36229844 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 96
Study 36090743 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation (24 sessions)
Number of subjects: 0
Study 36090743 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (3 sessions per week for around 60 min)
Number of subjects: 0
Study 35777773 — intervention group
Group type: EXPERIMENTAL
Intervention: F ENO-based asthma management (adjustment of asthma treatment according to exhaled nitric oxide and symptoms every 6-12 weeks)
Number of subjects: 1200
Study 35777773 — intervention group
Group type: EXPERIMENTAL
Intervention: F ENO-based asthma management
Number of subjects: 1200
Study 35777773 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no treatment adjustment as part of the trial)
Number of subjects: 1200
Study 35777773 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study 35339112 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity recommendations (PAR group)
Number of subjects: 65
Study 35339112 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT group)
Number of subjects: 65
Study 35339112 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT together with whole-body electromyostimulation (HIIT + EMS group)
Number of subjects: 65
Study 35339112 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 65
Study 32444994 — intervention group
Group type: EXPERIMENTAL
Intervention: BAX602 spray
Number of subjects: 30
Study 32444994 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 34256389 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced volume for a single set (RV1, n=20)
Number of subjects: 57
Study 34256389 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced volume for two sets (RV2, n=19)
Number of subjects: 57
Study 34256389 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintained volume of three sets (MV, n=18)
Number of subjects: 57
Study 34256389 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-conditioning phase (20 weeks)
Number of subjects: 57
Study 34256389 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 57
Study 34693688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellex (1 ml subcutaneously once daily for 10 days)
Number of subjects: 60
Study 32663909 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoglurant 5 mg
Number of subjects: 357
Study 32663909 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoglurant 15 mg
Number of subjects: 357
Study 32663909 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoglurant 30 mg
Number of subjects: 357
Study 32663909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study 35815985 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive bridging exercise
Number of subjects: 48
Study 35815985 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise
Number of subjects: 48
Study 34840669 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 0.5 mg/kg once a day, in the morning (MEL group)
Number of subjects: 36
Study 34840669 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 36
Study 34840669 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL group)
Number of subjects: 36
Study 33509400 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 33509400 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 33509400 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyles (specific foods and modest sunlight exposure)
Number of subjects: 0
Study 35057520 — intervention group
Group type: EXPERIMENTAL
Intervention: RF‐EMFs emitted by two different mobile phone types
Number of subjects: 15
Study 35057520 — intervention group
Group type: COMPARATOR
Intervention: Sham radiation
Number of subjects: 15
Study 33802115 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri‐Score (N‐S)
Number of subjects: 4504
Study 33802115 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL)
Number of subjects: 4504
Study 33802115 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 4504
Study 33802115 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Choice tick (PC)
Number of subjects: 4504
Study 33802115 — intervention group
Group type: COMPARATOR
Intervention: No label control
Number of subjects: 4504
Study 35199841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent Volume Assured Pressure Support (iVAPS)
Number of subjects: 80
Study 35199841 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous/timed (S/T) mode
Number of subjects: 80
Study 33882012 — intervention group
Group type: EXPERIMENTAL
Intervention: AI chatbot using bidirectional encoder representations from transformers model
Number of subjects: 118008
Study 33882012 — intervention group
Group type: EXPERIMENTAL
Intervention: AI chatbot using LSTM model with embedding vectors
Number of subjects: 118008
Study 34817419 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care and communication intervention for parents
Number of subjects: 110
Study 34817419 — intervention group
Group type: COMPARATOR
Intervention: Low-dose control
Number of subjects: 110
Study 32512690 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand-biased desks
Number of subjects: 97
Study 32512690 — intervention group
Group type: COMPARATOR
Intervention: Traditional sitting desks
Number of subjects: 97
Study 35286569 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 11
Study 35286569 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 11
Study 33617777 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (5 × 10^10 viral particles)
Number of subjects: 24178
Study 33617777 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine or saline placebo
Number of subjects: 24178
Study 32144955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib 480 mg
Number of subjects: 32
Study 32144955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib 160 mg
Number of subjects: 32
Study 32144955 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 32
Study 32144955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32185994 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency group (1 time/week for five weeks)
Number of subjects: 60
Study 32185994 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency group (2 times/week for two weeks)
Number of subjects: 60
Study 32185994 — intervention group
Group type: COMPARATOR
Intervention: Low frequency group
Number of subjects: 60
Study 32185994 — intervention group
Group type: COMPARATOR
Intervention: High frequency group
Number of subjects: 60
Study 34214161 — intervention group
Group type: EXPERIMENTAL
Intervention: T2D group (232 participants)
Number of subjects: 232
Study 34214161 — intervention group
Group type: EXPERIMENTAL
Intervention: DKD group (87 patients)
Number of subjects: 232
Study 34214161 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSs in TXNIP and CPT1A
Number of subjects: 232
Study 34214161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 232
Study 34214161 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic controls (197 participants)
Number of subjects: 232
Study 34362445 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month external implementation intervention including developmental evaluation, on-site visit, and monthly facilitation calls.
Number of subjects: 8
Study 35342923 — intervention group
Group type: EXPERIMENTAL
Intervention: LAIV4
Number of subjects: 151
Study 35342923 — intervention group
Group type: COMPARATOR
Intervention: IIV4
Number of subjects: 151
Study 33789322 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar orthosis (back brace) with back school instruction
Number of subjects: 61
Study 33789322 — intervention group
Group type: COMPARATOR
Intervention: Control group (education and exercise instruction alone)
Number of subjects: 61
Study 32487980 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic insoles with metatarsal retro-capital bar (MRCB)
Number of subjects: 20
Study 32487980 — intervention group
Group type: COMPARATOR
Intervention: Orthopedic insoles without correction (Control)
Number of subjects: 20
Study 36434739 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P39
Number of subjects: 146
Study 36434739 — intervention group
Group type: COMPARATOR
Intervention: EU-omalizumab
Number of subjects: 146
Study 36434739 — intervention group
Group type: COMPARATOR
Intervention: US-omalizumab
Number of subjects: 146
Study 33338583 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha 300 mg, twice daily, orally for 8 weeks
Number of subjects: 80
Study 33338583 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily, orally for 8 weeks
Number of subjects: 80
Study 36247201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary dietary pattern
Number of subjects: 1693
Study 36247201 — intervention group
Group type: COMPARATOR
Intervention: High-fat dietary pattern
Number of subjects: 1693
Study 32638144 — intervention group
Group type: EXPERIMENTAL
Intervention: HFHF enhanced with STS
Number of subjects: 248
Study 32638144 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 248
Study 36187084 — intervention group
Group type: EXPERIMENTAL
Intervention: EXER (loading programme specific to Achilles tendon combined with physical therapy)
Number of subjects: 60
Study 36187084 — intervention group
Group type: EXPERIMENTAL
Intervention: EXER and ESWT
Number of subjects: 60
Study 36187084 — intervention group
Group type: EXPERIMENTAL
Intervention: EXER, ESWT and PBMT
Number of subjects: 60
Study 36187084 — intervention group
Group type: COMPARATOR
Intervention: EXER
Number of subjects: 60
Study 36187084 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference and satisfaction with treatment
Number of subjects: 60
Study 35225548 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced plication with recession procedure
Number of subjects: 80
Study 35225548 — intervention group
Group type: COMPARATOR
Intervention: Standard resection with recession procedure
Number of subjects: 80
Study 34171280 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic-guided treatment group
Number of subjects: 66
Study 34171280 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 66
Study 35282825 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing with a conical shaped tip
Number of subjects: 44
Study 35282825 — intervention group
Group type: COMPARATOR
Intervention: Sonic scaling
Number of subjects: 44
Study 35282825 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 44
Study 35383741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized 3% hypertonic saline
Number of subjects: 100
Study 35383741 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.9%) with salbutamol
Number of subjects: 100
Study 32925650 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary IOL surgery
Number of subjects: 114
Study 32925650 — intervention group
Group type: COMPARATOR
Intervention: Primary IOL placement
Number of subjects: 114
Study 32925650 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary IOL surgery after 4½ years
Number of subjects: 114
Study 34981324 — intervention group
Group type: EXPERIMENTAL
Intervention: Long biliopancreatic Roux-en-Y gastric bypass (L-RYGB)
Number of subjects: 150
Study 34981324 — intervention group
Group type: COMPARATOR
Intervention: Standard Roux-en-Y gastric bypass (S-RYGB)
Number of subjects: 150
Study 35303017 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised multimodal exercise training (3x/week for 12 weeks)
Number of subjects: 42
Study 35303017 — intervention group
Group type: COMPARATOR
Intervention: Control group (physically inactive)
Number of subjects: 42
Study 35253836 — intervention group
Group type: COMPARATOR
Intervention: Left dorsolateral prefrontal cortex (DLPFC) stimulation (1 mA, 20 min)
Number of subjects: 254
Study 35253836 — intervention group
Group type: COMPARATOR
Intervention: Right dorsolateral prefrontal cortex (DLPFC) stimulation (1 mA, 20 min)
Number of subjects: 254
Study 32592273 — intervention group
Group type: EXPERIMENTAL
Intervention: Q switched KTP (532 nm) laser
Number of subjects: 30
Study 32592273 — intervention group
Group type: COMPARATOR
Intervention: Intra-dermal tranexamic acid (TXA) injections
Number of subjects: 30
Study 36018124 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.01% eye drops applied at night
Number of subjects: 0
Study 36018124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33220216 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with dihydroartemisinin-piperaquine
Number of subjects: 1000
Study 33220216 — intervention group
Group type: COMPARATOR
Intervention: Single screening and treatment with dihydroartemisinin-piperaquine
Number of subjects: 1000
Study 36049700 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose MVC-COV1901 (25 mcg)
Number of subjects: 420
Study 36049700 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-dose MVC-COV1901 (15 mcg)
Number of subjects: 420
Study 34331403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 50
Study 34331403 — intervention group
Group type: COMPARATOR
Intervention: Nuts (50 g day-1)
Number of subjects: 50
Study 32580577 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified multilayer bandage
Number of subjects: 150
Study 32580577 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohesive bandage
Number of subjects: 150
Study 32580577 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio-tape
Number of subjects: 150
Study 32580577 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive bandage
Number of subjects: 150
Study 32580577 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer bandage
Number of subjects: 150
Study 36195982 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message interventions (1-2 messages in the 3 days preceding appointment)
Number of subjects: 74811
Study 36195982 — intervention group
Group type: EXPERIMENTAL
Intervention: Top performing text message (described vaccine as 'reserved for you')
Number of subjects: 74811
Study 36195982 — intervention group
Group type: EXPERIMENTAL
Intervention: Other interventions
Number of subjects: 74811
Study 33460240 — intervention group
Group type: EXPERIMENTAL
Intervention: iACT (Internet-delivered acceptance and commitment therapy)
Number of subjects: 113
Study 33460240 — intervention group
Group type: COMPARATOR
Intervention: waitlist (control group)
Number of subjects: 113
Study 36200056 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (once-a-week)
Number of subjects: 37
Study 36200056 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (thrice-a-week)
Number of subjects: 37
Study 36200056 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity walking (once-a-week)
Number of subjects: 37
Study 36200056 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity walking (thrice-a-week)
Number of subjects: 37
Study 36200056 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise (Control group)
Number of subjects: 37
Study 36200056 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise groups (all types)
Number of subjects: 37
Study 32872077 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huayu Jiedu decoction
Number of subjects: 226
Study 34748469 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based active breaks intervention
Number of subjects: 146
Study 35760497 — intervention group
Group type: EXPERIMENTAL
Intervention: QUT Inspire app
Number of subjects: 24
Study 35760497 — intervention group
Group type: COMPARATOR
Intervention: Triflo II clinical ISy device
Number of subjects: 24
Study 32700215 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based diabetes self-management education (DSME) plus 6 months of mHealth-enhanced peer support (12 weekly phone calls, then 3 monthly calls)
Number of subjects: 120
Study 32700215 — intervention group
Group type: COMPARATOR
Intervention: Community-based diabetes self-management education (DSME) alone
Number of subjects: 120
Study 34145517 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Mania Questionnaire-9 (PMQ-9)
Number of subjects: 179
Study 33832054 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended depth of focus contact lenses
Number of subjects: 30
Study 32270891 — intervention group
Group type: EXPERIMENTAL
Intervention: HIT-RT exercise group (EG; n = 21)
Number of subjects: 43
Study 32270891 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n = 22)
Number of subjects: 43
Study 33452181 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg two times a day
Number of subjects: 710
Study 33452181 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg two times a day
Number of subjects: 710
Study 33452181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 710
Study 33452181 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (both dosages)
Number of subjects: 710
Study 33452181 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 710
Study 34835098 — intervention group
Group type: COMPARATOR
Intervention: Placebo group from a historic randomized controlled trial of ganciclovir for early treatment of CMV infection.
Number of subjects: 0
Study 33017168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral extra-articular tenodesis (LET) during simulated pivoting loads
Number of subjects: 7
Study 33017168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral extra-articular tenodesis (LET) during simulated anterior drawer test
Number of subjects: 7
Study 33017168 — intervention group
Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (without LET)
Number of subjects: 7
Study 33017168 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated Lachman test with LET
Number of subjects: 7
Study 33017168 — intervention group
Group type: COMPARATOR
Intervention: Simulated Lachman test without LET
Number of subjects: 7
Study 35367806 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (PREx), 24 sessions over 2 months, 3 sets of 8-10 repetitions of 8 whole-body exercises at moderate intensity
Number of subjects: 44
Study 35367806 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (PREx)
Number of subjects: 44
Study 35367806 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 34106081 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text message program for supporting self-management (Text4HeartII) for 24 weeks plus usual cardiac services
Number of subjects: 306
Study 34106081 — intervention group
Group type: COMPARATOR
Intervention: usual cardiac services
Number of subjects: 306
Study 33147073 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable respiratory monitor with daily in-application breathing exercise for 30 days
Number of subjects: 65
Study 33147073 — intervention group
Group type: COMPARATOR
Intervention: Control group received psychoeducation after completion of the study
Number of subjects: 65
Study 35512340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low linoleic acid foods with added DHA
Number of subjects: 559
Study 35512340 — intervention group
Group type: COMPARATOR
Intervention: HO-RUTF (High Oleic Acid Ready-to-Use Therapeutic Food)
Number of subjects: 559
Study 35512340 — intervention group
Group type: COMPARATOR
Intervention: S-RUTF (Standard Ready-to-Use Therapeutic Food)
Number of subjects: 559
Study 32139409 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (6000 mg/day)
Number of subjects: 1444
Study 32139409 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg/day)
Number of subjects: 1444
Study 34011376 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity (MVPA)
Number of subjects: 288
Study 34011376 — intervention group
Group type: COMPARATOR
Intervention: Female gender (versus males)
Number of subjects: 288
Study 34011376 — intervention group
Group type: COMPARATOR
Intervention: Obese weight status (versus non-obese)
Number of subjects: 288
Study 34011376 — intervention group
Group type: COMPARATOR
Intervention: Teaching in a middle school (versus elementary)
Number of subjects: 288
Study 34011376 — intervention group
Group type: EXPERIMENTAL
Intervention: Light physical activity (LPA)
Number of subjects: 288
Study 32854975 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative air ions
Number of subjects: 0
Study 32854975 — intervention group
Group type: COMPARATOR
Intervention: Particulate matter exposure
Number of subjects: 0
Study 35357352 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation (SL)
Number of subjects: 69